Technical Trend Shift and Price Movement
Fortis Healthcare’s share price closed at ₹878.05 on 10 Mar 2026, down 1.62% from the previous close of ₹892.50. The stock traded within a range of ₹857.00 to ₹883.25 during the day, remaining well below its 52-week high of ₹1,105.00 but comfortably above the 52-week low of ₹521.05. This recent price action aligns with the broader technical trend change, where the stock has moved from a sideways consolidation phase into a bearish trajectory.
The downgrade in the technical trend is underscored by the daily moving averages, which have turned bearish, signalling that short-term momentum is weakening. This is a critical development for investors who had previously observed a lack of clear directional bias in the stock’s price movements.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator presents a mildly bearish stance on both weekly and monthly charts. This suggests that the momentum behind recent price declines is gaining traction, although it is not yet at an extreme level. The MACD histogram has shown increasing negative divergence, indicating that selling pressure may persist in the near term.
Meanwhile, the Relative Strength Index (RSI) remains neutral on weekly and monthly timeframes, signalling no immediate overbought or oversold conditions. This lack of RSI signal implies that the stock’s price could continue to drift lower without triggering a technical rebound based on momentum exhaustion.
Bollinger Bands and Volatility Assessment
Bollinger Bands on the weekly chart have turned bearish, with the price approaching the lower band, which often acts as a support level. However, the monthly Bollinger Bands remain mildly bullish, indicating that longer-term volatility has not yet confirmed a sustained downtrend. This divergence between weekly and monthly volatility measures suggests that while short-term traders may face pressure, longer-term investors might find value in the current price levels.
Trend Confirmation via KST and Dow Theory
The Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change measures, confirms the bearish outlook on the weekly chart and mildly bearish on the monthly chart. This reinforces the view that momentum is weakening across multiple timeframes.
Dow Theory analysis adds further nuance: the weekly trend is mildly bearish, while the monthly trend shows no clear directional bias. This mixed signal suggests that while short-term technicals are deteriorating, the longer-term trend remains uncertain, warranting cautious positioning by investors.
Volume and On-Balance Volume (OBV) Insights
On-Balance Volume (OBV) indicators on both weekly and monthly charts show no discernible trend, indicating that volume has not decisively supported either buying or selling pressure. This lack of volume confirmation often precedes more volatile price moves, implying that investors should monitor volume closely for signs of a breakout or breakdown.
Comparative Returns and Market Context
Despite the recent technical deterioration, Fortis Healthcare’s long-term returns remain impressive. Over the past year, the stock has delivered a 39.37% return, significantly outperforming the Sensex’s 4.35% gain. Over three and five years, the stock’s returns stand at 219.99% and 383.91% respectively, dwarfing the Sensex’s 29.70% and 52.01% returns. Even on a 10-year horizon, Fortis has delivered a remarkable 410.94% return compared to the Sensex’s 212.84%.
However, in the short term, the stock has underperformed the benchmark. Over the past week, Fortis declined by 5.87% versus the Sensex’s 3.33% drop, and over the past month, it fell 1.49% while the Sensex dropped 7.73%. Year-to-date, Fortis is down 0.62%, outperforming the Sensex’s 8.98% decline but still showing signs of near-term weakness.
Market Capitalisation and Mojo Score
Fortis Healthcare holds a market cap grade of 2, reflecting its mid-cap status within the hospital sector. The company’s Mojo Score has deteriorated to 41.0, resulting in a downgrade from Hold to Sell on 6 Mar 2026. This downgrade reflects the accumulation of bearish technical signals and the weakening momentum observed across multiple indicators.
Investor Takeaway and Outlook
Fortis Healthcare’s technical downgrade and bearish momentum indicators suggest caution for short-term traders and investors. The daily moving averages and weekly MACD point to increasing selling pressure, while the neutral RSI and lack of volume confirmation imply that the stock could continue to drift lower without immediate relief.
Long-term investors may find comfort in the stock’s strong historical returns and the mildly bullish monthly Bollinger Bands, which hint at potential support at current levels. However, the downgrade to a Sell rating by MarketsMOJO and the shift in technical trend from sideways to bearish indicate that risk management and close monitoring are essential in the near term.
Given the mixed signals from monthly and weekly indicators, investors should watch for confirmation of trend direction through volume spikes or a reversal in momentum indicators before committing to fresh positions. The hospital sector’s fundamentals and Fortis’s market position remain important considerations alongside technical analysis.
Summary of Key Technical Indicators
- Trend: Shifted from sideways to bearish
- MACD: Weekly and monthly mildly bearish
- RSI: Neutral on weekly and monthly
- Bollinger Bands: Weekly bearish, monthly mildly bullish
- Moving Averages: Daily bearish
- KST: Weekly bearish, monthly mildly bearish
- Dow Theory: Weekly mildly bearish, monthly no trend
- OBV: No trend on weekly and monthly
Investors should weigh these technical signals carefully against Fortis Healthcare’s valuation and sector outlook before making investment decisions.
Limited Period Only. Get Started for only Rs. 16,999 – Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
